Impact of Obesity on Risk of Hospitalization, Surgery and Serious Infection in Biologic-treated Patients with Inflammatory Bowel Diseases: A CA-IBD Cohort Study.

In a multicenter, EHR-based cohort of biologic-treated patients with IBD, obesity was not associated with hospitalization, surgery, or serious infections. Further studies examining the impact of visceral obesity on patient-reported and endoscopic outcomes are needed.